Suchergebnisse - "Hughes, Carly M"

PubPharm (9)

1

Clinical illness with viable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) virus presenting 72 days after infection in an immunocompromised patient

enthalten in: Infection control and hospital epidemiology | 2022

von Hughes, C. | Gregory, G. | Pierce, A. | +14

2

Prospective study of policies and use of therapies for COVID-19 among Australian health services during 2020

enthalten in: Internal medicine journal | 2022

von Smith, E. | Gwee, A. | Roberts, J. | +4

3

Prospective study of policies and use of therapies for COVID‐19 among Australian health services during 2020

enthalten in: Internal Medicine Journal | 2022

von Smith, E. | Gwee, A. | Roberts, J. | +4

4

Integrated immune dynamics define correlates of COVID-19 severity and antibody responses

enthalten in: Cell reports. Medicine | 2021

von Koutsakos, M. | Rowntree, L. | Hensen, L. | +41

5

Incidental mucocutaneous cytomegalovirus detection and its predictive value for systemic disease

enthalten in: Pathology | 2020

von Hughes, C. | Spring, S. | Radalage, R. | +3

6

CRyptOcoccosis in Newcastle and the hUnTer (CRONUT) - An epidemiological study

enthalten in: Infection, disease & health | 2020

von Hughes, C. | Lennon, D. | Davis, J.

7

Acquired multidrug‐resistant Candida glabrata in Australia : a case report

enthalten in: Journal of Pharmacy Practice and Research | 2019

von Koch, J. | Harding, E. | Hughes, C.

8

Risk factors for relapse or persistence of bacteraemia caused by Enterobacter spp.: a case–control study

enthalten in: Antimicrobial resistance and infection control | 2017

von Harris, P. | Peri, A. | Pelecanos, A. | +3

9

Risk factors for relapse or persistence of bacteraemia caused by Enterobacter spp. : a case-control study

enthalten in: Antimicrobial resistance and infection control | 2017

von Harris, P. | Peri, A. | Pelecanos, A. | +3

1
[1]